Ravindra Kumar, SVP & Chief Scientific Officer at ACCELERON PHARMA INC (XLRN), sold 16,009 shares at $34.31 ($550K) on 2016-10-06, disclosed to the SEC on 2016-10-11.
Open-market sale of $550k XLRN by SVP & Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.31 | 14,448 | $496K | 90.1% |
| 2 | $34.98 | 1,561 | $55K | 9.9% |
| Total | $34.38 avg | 16,009 | $550K | 100% |
| Filing → |
| XLRN | SELL | 2019-01-04 | $232K | — | Filing → |
| XLRN | SELL | 2018-01-04 | $182K | — | Filing → |
| XLRN | SELL | 2017-09-14 | $176K | — | Filing → |